A Phase 1/2 Study to Evaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association with the MYC Oncogene

Clinical trial NCT05497453 · TERMINATED

Trial details

NCT number: NCT05497453
Sponsor: Omega Therapeutics
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Solid Tumor Hepatocellular Carcinoma Non-resectable Hepatocellular Carcinoma Recurrent Hepatocellular Cancer Liver Cancer Liver, Cancer Of, Non-Resectable

Start date: 2022-08-19
Primary completion: 2024-11-21
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.